SCHEMBL14367443

SCHEMBL14367443

COc1ccc(-c2cc(C(F)(F)F)n3nc(C(=O)N(C)Cc4cn(C)nc4C)c(Cl)c3n2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.56
CASP1 P29466 5/20 0.56
CASP7 P55210 3/20 0.56
GAA P10253 2/20 0.56
HPGD P15428 5/20 0.54
CYP3A4 P08684 2/20 0.54
CYP2C9 P11712 2/20 0.54
CYP2C19 P33261 2/20 0.54
NPSR1 Q6W5P4 2/20 0.54
CYP1A2 P05177 1/20 0.54
RXFP1 Q9HBX9 3/20 0.53
POLB P06746 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.52
MAPK1 P28482 2/20 0.52
KDM4E B2RXH2 5/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 5/20 0.51
HSD17B10 Q99714 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1718578 0.85 ALDH1A1 (0.71) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL1719266 0.78 MAPT (0.78) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL4205112 0.78 MAPT (0.72) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL4217014 0.77 ALDH1A1 (0.63) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL1719255 0.77 ALDH1A1 (0.57) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL14367444 0.77 ALDH1A1 (0.71) ALDH1A1CASP1CASP7HPGDNPSR1
SCHEMBL14367630 0.77 KDM4E (0.61) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL1718686 0.76 ALDH1A1 (0.58) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL1718176 0.75 ALDH1A1 (0.57) ALDH1A1CASP1CASP7GAAHPGD
SCHEMBL1719465 0.74 ALDH1A1 (0.72) ALDH1A1CASP1CASP7GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines NOVO NORDISK A/S (DK) 2007-11-22 US disclosed
EP-1782859-A2 Pharmaceutical use of substituted pyrazolo [1,5- a]pyrimidines NOVO NORDISK A/S (DK) 2007-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270408-A1 Pharmaceutical use of substituted pyrazolo[1,5-a]pyrimidines HSD3B1, HSD11B1, SRD5A1 ALDH1A1 133/4885CASP1 992/4885CASP7 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.